Latest Articles

Publication Date
Medicus Pharma receives UAE approval for endometriosis study By Investing.com - Investing.com Canada

Medicus Pharma receives UAE approval for endometriosis study By Investing.com Investing.com Canada

Published: July 31, 2026, 11:39 a.m.
About 84 Women, Four Groups: Teverelix Endometriosis Trial - Stock Titan

About 84 Women, Four Groups: Teverelix Endometriosis Trial Stock Titan

Published: July 31, 2026, 11:30 a.m.
EXCLUSIVE: Medicus Pharma Launches Genomics-Guided Endometriosis Study In Abu Dhabi - Benzinga

EXCLUSIVE: Medicus Pharma Launches Genomics-Guided Endometriosis Study In Abu Dhabi Benzinga

Published: July 31, 2026, 11:15 a.m.
Karyopharm shares crater on second Phase 3 flop for Xpovio in endometrial cancer - Endpoints News

Karyopharm shares crater on second Phase 3 flop for Xpovio in endometrial cancer Endpoints News

Published: July 31, 2026, 10:42 a.m.
Understanding Endometriosis Cysts That Are Said to Make It Difficult to Get Pregnant, Is It True? - VOI.ID

Understanding Endometriosis Cysts That Are Said to Make It Difficult to Get Pregnant, Is It True? VOI.ID

Published: July 31, 2026, 10:37 a.m.
Understanding Endometriosis Cysts That Are Said to Make It Difficult to Get Pregnant, Is It True? - VOI.id

Understanding Endometriosis Cysts That Are Said to Make It Difficult to Get Pregnant, Is It True? VOI.id

Published: July 31, 2026, 10:37 a.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - Proactive financial news

Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix Proactive financial news

Published: July 31, 2026, 9:24 a.m.
Minnesota writers bring endometriosis musical to Edinburgh Fringe - MPR News

Minnesota writers bring endometriosis musical to Edinburgh Fringe MPR News

Published: July 31, 2026, 9 a.m.
Endometriosis Couple Coping: Key Insights and Care Models - OC Academy

Endometriosis Couple Coping: Key Insights and Care Models OC Academy

Published: July 31, 2026, 5:41 a.m.
Selinexor Misses Primary Endpoint in Endometrial Cancer Trial - Medical Professionals Reference

Selinexor Misses Primary Endpoint in Endometrial Cancer Trial Medical Professionals Reference

Published: July 31, 2026, 4 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!